Citigroup Inc Scholar Rock Holding Corp Transaction History

Citigroup Inc

$153 Billion
Q2 2024

A detailed history of Citigroup Inc transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Citigroup Inc holds 269,281 shares of SRRK stock, worth $2.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

269,281

Previous 536,329 49.79%

Holding current value

$2.35 Million

Previous $9.53 Million 76.45%

% of portfolio

0.0%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$7.84 - $16.79 $2.09 Million - $4.48 Million	-267,048 Reduced 49.79%	269,281 $2.24 Million
Q1 2024 May 10, 2024	BUY	$13.2 - $17.76 $6.42 Million - $8.64 Million	486,619 Added 978.92%	536,329 $9.53 Million
Q4 2023 Feb 09, 2024	BUY	$6.52 - $20.32 $318,684 - $993,200	48,878 Added 5874.76%	49,710 $934,000
Q3 2023 Nov 09, 2023	SELL	$6.02 - $7.76 $57,189 - $73,720	-9,500 Reduced 91.95%	832 $5,000
Q2 2023 Aug 10, 2023	SELL	$5.79 - $9.11 $603,711 - $949,881	-104,268 Reduced 90.98%	10,332 $77,000
Q1 2023 May 11, 2023	SELL	$7.36 - $12.72 $736 - $1,272	-100 Reduced 0.09%	114,600 $916,000
Q4 2022 Feb 09, 2023	BUY	$7.02 - $9.76 $779,381 - $1.08 Million	111,023 Added 3019.39%	114,700 $1.04 Million
Q3 2022 Nov 10, 2022	BUY	$5.33 - $11.3 $9,514 - $20,170	1,785 Added 94.34%	3,677 $25,000
Q2 2022 Aug 10, 2022	SELL	$4.66 - $13.96 $58,287 - $174,611	-12,508 Reduced 86.86%	1,892 $11,000
Q1 2022 May 12, 2022	SELL	$11.89 - $24.68 $516,549 - $1.07 Million	-43,444 Reduced 75.11%	14,400 $186,000
Q4 2021 Feb 10, 2022	BUY	$24.14 - $35.18 $710,560 - $1.04 Million	29,435 Added 103.61%	57,844 $1.44 Million
Q3 2021 Nov 10, 2021	BUY	$27.38 - $42.21 $777,838 - $1.2 Million	28,409 New	28,409 $938,000

Others Institutions Holding SRRK

# of Institutions

170

Shares Held

74.9M

Call Options Held

151K

Put Options Held

40.1K

View Full List

About Scholar Rock Holding Corp

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $451M
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

More about SRRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account